BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sidransky D, Hollstein M. Clinical implications of the p53 gene. Annu Rev Med. 1996;47:285-301. [PMID: 8712782 DOI: 10.1146/annurev.med.47.1.285] [Cited by in Crossref: 110] [Cited by in F6Publishing: 91] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Shpitz B, Tiomkin V, Bomstein Y, Gralkin M, Buklan H, Bernheim J, Klein E. Evaluation of putative molecular biomarkers in abdominal and retroperitoneal leiomyosarcomas. European Journal of Surgical Oncology (EJSO) 2001;27:203-8. [DOI: 10.1053/ejso.2000.1074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
2 Shaham J, Fireman E, Korenstein-ilan A, Lerman Y. Detection of p53 Protein in Induced Sputum After Occupational Exposure to Crystalline Silica. Journal of Occupational & Environmental Medicine 2007;49:730-5. [DOI: 10.1097/jom.0b013e31805d0be4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Zou C, Guan Y, Zou C, Wang J, Wang L, Liebert M, Grossman H, Wei Q. N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines. Cancer Letters 2002;180:131-7. [DOI: 10.1016/s0304-3835(01)00864-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Isaksson E, Cline J, Skoog L, Söderqvist G, Wilking N, von Schoultz E, von Schoultz B. p53 expression in breast and endometrium during estrogen and tamoxifen treatment of surgically postmenopausal cynomolgus macaques. Breast Cancer Res Treat 1999;53:61-7. [DOI: 10.1023/a:1006172025349] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Choi YD, Choi J, Kim JH, Lee JS, Lee JH, Choi C, Choi HS, Lee MC, Park CS, Juhng SW, Nam JH. Microsatellite instability at a tetranucleotide repeat in type I endometrial carcinoma. J Exp Clin Cancer Res 2008;27:88. [PMID: 19116039 DOI: 10.1186/1756-9966-27-88] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ahrendt SA, Brown HM, Komorowski RA, Zhu YR, Wilson SD, Erickson BA, Ritch PS, Pitt HA, Demeure MJ. p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer. Surgery 2000;128:520-30. [PMID: 11015084 DOI: 10.1067/msy.2000.108052] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
7 Wang YW, Zhang K, Zhao S, Lv Y, Zhu J, Liu H, Feng J, Liang W, Ma R, Wang J. HPV Status and Its Correlation with BCL2, p21, p53, Rb, and Survivin Expression in Breast Cancer in a Chinese Population. Biomed Res Int. 2017;2017:6315392. [PMID: 29423411 DOI: 10.1155/2017/6315392] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
8 Ponce YM, Marrero RM, Castro EA, Ramos de Armas R, Díaz HG, Zaldivar VR, Torrens F. Protein quadratic indices of the "macromolecular pseudograph's alpha-carbon atom adjacency matrix". 1. Prediction of Arc repressor alanine-mutant's stability. Molecules 2004;9:1124-47. [PMID: 18007508 DOI: 10.3390/91201124] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
9 Ozbey U, Yüce H, Namli M, Elkiran T. Investigation of Differences in P53 Gene Polymorphisms between Schizophrenia and Lung Cancer Patients in the Turkish Population. Genet Res Int 2011;2011:483851. [PMID: 22567355 DOI: 10.4061/2011/483851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
10 Sionov RV, Haupt Y. Apoptosis by p53: mechanisms, regulation, and clinical implications. Springer Semin Immunopathol 1998;19:345-62. [PMID: 9540161 DOI: 10.1007/BF00787230] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
11 Handel-fernandez L, Vincek V. Early cancer detection by microsatellite marker analysis. Medical Hypotheses 1999;53:114-7. [DOI: 10.1054/mehy.1998.0727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
12 Conner P, Register TC, Skoog L, Tani E, von Schoultz B, Cline JM. Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys. American Journal of Obstetrics and Gynecology 2005;193:58-63. [DOI: 10.1016/j.ajog.2004.11.056] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
13 Huth L, Jäkel J, Dahl E. Molecular Diagnostic Applications in Colorectal Cancer. Microarrays (Basel) 2014;3:168-79. [PMID: 27600342 DOI: 10.3390/microarrays3030168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
14 Zou C, Liebert M, Zou C, Grossman HB, Lotan R. IDENTIFICATION OF EFFECTIVE RETINOIDS FOR INHIBITING GROWTH AND INDUCING APOPTOSIS IN BLADDER CANCER CELLS. Journal of Urology 2001;165:986-92. [DOI: 10.1016/s0022-5347(05)66589-5] [Cited by in Crossref: 25] [Article Influence: 1.2] [Reference Citation Analysis]
15 Dazard JE, Piette J, Basset-Seguin N, Blanchard JM, Gandarillas A. Switch from p53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular size. Oncogene. 2000;19:3693-3705. [PMID: 10949923 DOI: 10.1038/sj.onc.1203695] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.0] [Reference Citation Analysis]
16 Chen H, Wang LD, Guo M, Gao SG, Guo HQ, Fan ZM, Li JL. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. World J Gastroenterol 2003; 9(1): 16-21 [PMID: 12508343 DOI: 10.3748/wjg.v9.i1.16] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
17 Li Y, Qiu LX, Shen XK, Lv XJ, Qian XP, Song Y. A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects. Lung Cancer 2009;66:15-21. [PMID: 19178978 DOI: 10.1016/j.lungcan.2008.12.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
18 Higginbottom K, Jahnke U, Newland AC, Cotter FE, Allen PD. New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis. Apoptosis 2007;12:1847-55. [PMID: 17636382 DOI: 10.1007/s10495-007-0104-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kourkine IV, Hestekin CN, Buchholz BA, Barron AE. High-throughput, high-sensitivity genetic mutation detection by tandem single-strand conformation polymorphism/heteroduplex analysis capillary array electrophoresis. Anal Chem 2002;74:2565-72. [PMID: 12069238 DOI: 10.1021/ac020025b] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
20 Zhang Y, Tan Y, Dong C, Gao S, Xu W, Chen H. Evaluating the scope of intramedullary invasion of malignant bone tumor by DCE-MRI quantitative parameters in animal study. J Bone Oncol 2019;19:100269. [PMID: 31799112 DOI: 10.1016/j.jbo.2019.100269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
21 Musumarra G, Trovato-salinaro A, Scirè S, Foti A, Barresi V, Fortuna CG, Strazzulla G, Condorelli DF. Identification of genes involved in radiation-induced G1 arrest. J Chemometrics 2007;21:398-405. [DOI: 10.1002/cem.1080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
22 Ferguson PC, Boynton EL, Wunder JS, Hill RP, O'sullivan B, Sandhu JS, Bell RS. Intradermal Injection of Autologous Dermal Fibroblasts Improves Wound Healing in Irradiated Skin. Journal of Surgical Research 1999;85:331-8. [DOI: 10.1006/jsre.1999.5664] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
23 Ozbun LL, You L, Kiang S, Angdisen J, Martinez A, Jakowlew SB. Identification of Differentially Expressed Nucleolar TGF-β1 Target (DENTT) in Human Lung Cancer Cells That Is a New Member of the TSPY/SET/NAP-1 Superfamily. Genomics 2001;73:179-93. [DOI: 10.1006/geno.2001.6505] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
24 Bellizzi AM. Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms. Seminars in Diagnostic Pathology 2013;30:329-61. [DOI: 10.1053/j.semdp.2013.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
25 Jinturkar KA, Anish C, Kumar MK, Bagchi T, Panda AK, Misra AR. Liposomal formulations of Etoposide and Docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines. Biomaterials 2012;33:2492-507. [PMID: 22200537 DOI: 10.1016/j.biomaterials.2011.11.067] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
26 Grace VM, Shalini JV, lekha TT, Devaraj SN, Devaraj H. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 2003;91:51-58. [PMID: 14529662 DOI: 10.1016/S0090-8258(03)00439-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
27 Kim C, Choi E, Choi S, Park J, Haider KH, Ahn WS. Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC. Gynecologic Oncology 2003;90:265-72. [DOI: 10.1016/s0090-8258(03)00248-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
28 Tian XX, Chan JY, Pang JC, Chen J, He JH, To TS, Leung SF, Ng HK. Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor. Br J Cancer 1999;81:994-1001. [PMID: 10576656 DOI: 10.1038/sj.bjc.6690798] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
29 Salgia R, Li J, Ewaniuk DS, Wang Y, Sattler M, Chen W, Richards W, Pisick E, Shapiro GI, Rollins BJ, Chen LB, Griffin JD, Sugarbaker DJ. Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility. Oncogene 1999;18:67-77. [DOI: 10.1038/sj.onc.1202273] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 2.7] [Reference Citation Analysis]
30 Lumachi F, Marino F, Varotto S, Basso U. Oligonucleotide probe array for p53 gene alteration analysis in DNA from formalin-fixed paraffin-embedded breast cancer tissues. Ann N Y Acad Sci 2009;1175:89-92. [PMID: 19796081 DOI: 10.1111/j.1749-6632.2009.04969.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
31 Tessitore A, Di Rocco ZC, Cannita K, Ricevuto E, Toniato E, Tosi M, Ficorella C, Frati L, Gulino A, Marchetti P, Martinotti S. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis. Genes Chromosomes Cancer 2002;35:86-91. [PMID: 12203794 DOI: 10.1002/gcc.10102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
32 Groopman JD, Kensler TW. Role of metabolism and viruses in aflatoxin-induced liver cancer. Toxicol Appl Pharmacol 2005;206:131-7. [PMID: 15967201 DOI: 10.1016/j.taap.2004.09.020] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 4.2] [Reference Citation Analysis]
33 Wogan GN, Kensler TW, Groopman JD. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2012;29:249-57. [PMID: 21623489 DOI: 10.1080/19440049.2011.563370] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 6.6] [Reference Citation Analysis]
34 Biroš E, Kalina I, Kohút A, Štubňa J, Šalagovič J. Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer. Lung Cancer 2001;31:157-62. [DOI: 10.1016/s0169-5002(00)00188-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
35 Ganti AK, Panwalkar AW. Targeted therapy for small cell lung cancer. Targ Oncol 2007;2:89-97. [DOI: 10.1007/s11523-007-0045-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Ahrendt SA, Halachmi S, Chow JT, Wu L, Halachmi N, Yang SC, Wehage S, Jen J, Sidransky D. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. Proc Natl Acad Sci U S A 1999;96:7382-7. [PMID: 10377423 DOI: 10.1073/pnas.96.13.7382] [Cited by in Crossref: 143] [Cited by in F6Publishing: 139] [Article Influence: 6.2] [Reference Citation Analysis]
37 Trepel M, Groscurth P, Malipiero U, Gulbins E, Dichgans J, Weller M. Chemosensitivity of human malignant glioma: modulation by p53 gene transfer. J Neurooncol 1998;39:19-32. [PMID: 9760067 DOI: 10.1023/a:1005910323338] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
38 Rubinfeld H, Seger R. The ERK cascade: a prototype of MAPK signaling. Mol Biotechnol. 2005;31:151-174. [PMID: 16170216 DOI: 10.1385/mb:31:2:151] [Cited by in Crossref: 287] [Cited by in F6Publishing: 142] [Article Influence: 17.9] [Reference Citation Analysis]
39 Xu N, Shiraki T, Yamada T, Nakajima M, Gauthier JM, Pfeiffer CJ, Sato S. Nucleotide sequence of the p53 cDNA of beluga whale (Delphinapterus leucas). Gene 2002;288:159-66. [DOI: 10.1016/s0378-1119(02)00472-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Luke JJ, Van De Wetering CI, Knudson CM. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability. Cell Death Differ 2003;10:740-8. [PMID: 12761582 DOI: 10.1038/sj.cdd.4401233] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
41 He Q, Zhang SQ, Chu YL, Jia XL, Wang XL. The correlations between HPV16 infection and expressions of c-erbB-2 and bcl-2 in breast carcinoma. Mol Biol Rep 2009;36:807-12. [PMID: 18427947 DOI: 10.1007/s11033-008-9249-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
42 Kato T, Kolenic N, Pardini RS. Docosahexaenoic Acid (DHA), a Primary Tumor Suppressive Omega-3 Fatty Acid, Inhibits Growth of Colorectal Cancer Independent of p53 Mutational Status. Nutrition and Cancer 2007;58:178-87. [DOI: 10.1080/01635580701328362] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
43 Hollstein M, Moeckel G, Hergenhahn M, Spiegelhalder B, Keil M, Werle-Schneider G, Bartsch H, Brickmann J. On the origins of tumor mutations in cancer genes: insights from the p53 gene. Mutat Res 1998;405:145-54. [PMID: 9748548 DOI: 10.1016/s0027-5107(98)00131-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
44 Israels ED, Israels LG. The cell cycle. Stem Cells. 2001;19:88-91. [PMID: 11209094 DOI: 10.1634/stemcells.19-1-88] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 2.0] [Reference Citation Analysis]
45 Xing Y, Ning Y, Ru LQ, Wang LD. Expressions of PCNA, p53, p21WAF-1 and cell proliferation in fetal esophageal epithelia: Comparative study with adult esophageal lesions from subjects at high-incidence area for esophageal cancer in Henan, North China. World J Gastroenterol 2003; 9(7): 1601-1603 [PMID: 12854173 DOI: 10.3748/wjg.v9.i7.1601] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
46 Huber M, Losert D, Hiller R, Harwanegg C, Mueller MW, Schmidt WM. Detection of Single Base Alterations in Genomic DNA by Solid Phase Polymerase Chain Reaction on Oligonucleotide Microarrays. Analytical Biochemistry 2001;299:24-30. [DOI: 10.1006/abio.2001.5355] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
47 Hann CL, Rudin CM. Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer. Trends Mol Med 2007;13:150-7. [PMID: 17324626 DOI: 10.1016/j.molmed.2007.02.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
48 Fu DJ, Tang K, Braun A, Reuter D, Darnhofer-Demar B, Little DP, O'Donnell MJ, Cantor CR, Köster H. Sequencing exons 5 to 8 of the p53 gene by MALDI-TOF mass spectrometry. Nat Biotechnol 1998;16:381-4. [PMID: 9555731 DOI: 10.1038/nbt0498-381] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 3.7] [Reference Citation Analysis]
49 Gallagher W, Brown R. p53-Oriented cancer therapies: Current progress. Annals of Oncology 1999;10:139-50. [DOI: 10.1023/a:1008368500557] [Cited by in Crossref: 27] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
50 Ecke TH, Schlechte HH, Gunia S, Lenk SV, Loening SA. Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancer. Urologic Oncology: Seminars and Original Investigations 2008;26:470-3. [DOI: 10.1016/j.urolonc.2007.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
51 Patne SCU, Abhilash VB, Dixit VK, Katiyar R, Kumar S, Singh GP. Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 (HER2) and p53 in Gastric Adenocarcinoma: A Pilot Study from Northern India. J Clin Diagn Res 2017;11:EC43-5. [PMID: 28658772 DOI: 10.7860/JCDR/2017/25650.9921] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Lee JH, Hong YS, Ryu JS, Chang JH. p53 and FHIT mutations and microsatellite alterations in malignancy-associated pleural effusion. Lung Cancer 2004;44:33-42. [PMID: 15013581 DOI: 10.1016/j.lungcan.2003.10.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
53 Mitra T, Mohanty BP, Mohanty S, Purohit GK, Das BK. Expression patterns and mutation analysis of p53 in fish Rita rita from polluted riverine environment. Mutat Res Genet Toxicol Environ Mutagen 2018;832-833:41-51. [PMID: 30057020 DOI: 10.1016/j.mrgentox.2018.05.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
54 Forgacs E, Zöchbauer-müller S, Oláh E, Minna JD. Molecular genetic abnormalities in the pathogenesis of human lung cancer. Pathol Oncol Res 2001;7:6-13. [DOI: 10.1007/bf03032598] [Cited by in Crossref: 54] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
55 Pillai MR, Phanidhara A, Kesari AL, Nair P, Nair MK. Cellular manifestations of human papillomavirus infection in the oral mucosa. J Surg Oncol 1999;71:10-5. [DOI: 10.1002/(sici)1096-9098(199905)71:1<10::aid-jso3>3.0.co;2-v] [Cited by in Crossref: 29] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
56 Pisick E, Jagadeesh S, Salgia R. Small cell lung cancer: from molecular biology to novel therapeutics. J Exp Ther Oncol 2003;3:305-18. [PMID: 14678519 DOI: 10.1111/j.1533-869x.2003.01103.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
57 Nair P, Nair KM, Jayaprakash PG, Pillai MR. Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection. Pathol Oncol Res 1999;5:95-103. [PMID: 10393359 DOI: 10.1053/paor.1999.0161] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 1.4] [Reference Citation Analysis]
58 Roth S, Partanen T, Suitiala T, Anttila S, Ojajärvi A, Hemminki K, Vainio H, Husgafvel-Pursiainen K. Molecular analysis of occupational cancer: infrequent p53 and ras mutations in renal-cell cancer in workers exposed to gasoline. Int J Cancer 1997;73:492-6. [PMID: 9389561 DOI: 10.1002/(sici)1097-0215(19971114)73:4<492::aid-ijc6>3.0.co;2-v] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Liloglou T, Ross H, Prime W, Donnelly RJ, Spandidos DA, Gosney JR, Field JK. p53 gene aberrations in non-small-cell lung carcinomas from a smoking population. Br J Cancer 1997;75:1119-24. [PMID: 9099958 DOI: 10.1038/bjc.1997.193] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
60 Kaur J, Srivastava A, Ralhan R. Prognostic significance of p53 protein overexpression in betel- and tobacco-related oral oncogenesis. Int J Cancer 1998;79:370-5. [DOI: 10.1002/(sici)1097-0215(19980821)79:4<370::aid-ijc11>3.0.co;2-9] [Cited by in Crossref: 19] [Article Influence: 0.8] [Reference Citation Analysis]
61 Bumroongkit K, Rannala B, Traisathit P, Srikummool M, Wongchai Y, Kangwanpong D. TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors. Cancer Genetics and Cytogenetics 2008;185:20-7. [DOI: 10.1016/j.cancergencyto.2008.04.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
62 Sadri Nahand J, Esghaei M, Hamidreza Monavari S, Moghoofei M, Jalal Kiani S, Mostafaei S, Mirzaei H, Bokharaei-Salim F. The assessment of a possible link between HPV-mediated inflammation, apoptosis, and angiogenesis in Prostate cancer. Int Immunopharmacol 2020;88:106913. [PMID: 32889239 DOI: 10.1016/j.intimp.2020.106913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
63 Minamoto T, Mai M, Ronai Z. Environmental factors as regulators and effectors of multistep carcinogenesis. Carcinogenesis 1999;20:519-27. [PMID: 10223177 DOI: 10.1093/carcin/20.4.519] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 3.2] [Reference Citation Analysis]
64 Vinyals A, Peinado MA, Gonzalez-Garrigues M, Monzó M, Bonfil RD, Fabra A. Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein. Gene Ther. 1999;6:22-33. [PMID: 10341872 DOI: 10.1038/sj.gt.3300786] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
65 Ravi D, Das KC. Redox-cycling of anthracyclines by thioredoxin system: increased superoxide generation and DNA damage. Cancer Chemother Pharmacol 2004;54:449-58. [PMID: 15290096 DOI: 10.1007/s00280-004-0833-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
66 Norberg T, Klaar S, Lindqvist L, Lindahl T, Ahlgren J, Bergh J. Enzymatic Mutation Detection Method Evaluated for Detection of p53 Mutations in cDNA from Breast Cancers. Clinical Chemistry 2001;47:821-8. [DOI: 10.1093/clinchem/47.5.821] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Sattler M, Salgia R. Molecular and cellular biology of small cell lung cancer. Seminars in Oncology 2003;30:57-71. [DOI: 10.1053/sonc.2003.50019] [Cited by in Crossref: 52] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
68 Jun HJ, Nguyen AH, Kim YH, Park KH, Kim D, Kim KK, Sim SJ. Distinct Rayleigh scattering from hot spot mutant p53 proteins reveals cancer cells. Small 2014;10:2954-62. [PMID: 24700814 DOI: 10.1002/smll.201400004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
69 Khan SA, Thomas HC, Toledano MB, Cox IJ, Taylor-Robinson SD. p53 Mutations in human cholangiocarcinoma: a review. Liver Int. 2005;25:704-716. [PMID: 15998419 DOI: 10.1111/j.1478-3231.2005.01106.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
70 Ha PK, Califano JA 3rd. The molecular biology of laryngeal cancer. Otolaryngol Clin North Am 2002;35:993-1012. [PMID: 12587244 DOI: 10.1016/s0030-6665(02)00038-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
71 Marie SK, Shinjo SM. Metabolism and brain cancer. Clinics (Sao Paulo) 2011;66 Suppl 1:33-43. [PMID: 21779721 DOI: 10.1590/s1807-59322011001300005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
72 Worden FP, Kalemkerian GP. Lung cancer. Cancer Treat Res 2001;106:183-219. [PMID: 11225003 DOI: 10.1007/978-1-4615-1657-6_8] [Reference Citation Analysis]
73 Yokomizo A, Mai M, Bostwick DG, Tindall DJ, Qian J, Cheng L, Jenkins RB, Smith DI, Liu W. Mutation and expression analysis of the p73 gene in prostate cancer. Prostate 1999;39:94-100. [PMID: 10221564 DOI: 10.1002/(sici)1097-0045(19990501)39:2<94::aid-pros3>3.0.co;2-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
74 Fan C. Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair. Curr Oncol Rep 2001;3:66-71. [DOI: 10.1007/s11912-001-0045-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
75 Rangel-López A, Maldonado-Rodríguez R, Salcedo-Vargas M, Espinosa-Lara JM, Méndez-Tenorio A, Beattie KL. Low density DNA microarray for detection of most frequent TP53 missense point mutations. BMC Biotechnol 2005;5:8. [PMID: 15713227 DOI: 10.1186/1472-6750-5-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
76 Xu L, Pirollo KF, Chang EH. Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy. J Control Release. 2001;74:115-128. [PMID: 11489488 DOI: 10.1016/S0168-3659(01)00324-8] [Cited by in Crossref: 92] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
77 Shpitz B, Bomstein Y, Sternberg A, Klein E, Liverant S, Groisman G, Bernheim J. Angiogenesis, p53, and c-erbB-2 immunoreactivity and clinicopathological features in male breast cancer. J Surg Oncol 2000;75:252-7. [DOI: 10.1002/1096-9098(200012)75:4<252::aid-jso5>3.0.co;2-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
78 Zhang N, Pei F, Wei H, Zhang T, Yang C, Ma G, Yang C. Isorhamnetin protects rat ventricular myocytes from ischemia and reperfusion injury. Exp Toxicol Pathol 2011;63:33-8. [PMID: 19815400 DOI: 10.1016/j.etp.2009.09.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
79 Klumb CENP, Resende LMMD, Tajara EH, Bertelli ECP, Rumjanek VM, Maia RC. p53 gene analysis in childhood B non - Hodgkin's lymphoma. Sao Paulo Med J 2001;119:212-5. [DOI: 10.1590/s1516-31802001000600006] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
80 Yang Q, Wesch H, Mueller KM, Bartsch H, Wegener K, Hollstein M. Analysis of radon-associated squamous cell carcinomas of the lung for a p53 gene hotspot mutation. Br J Cancer 2000;82:763-6. [PMID: 10732742 DOI: 10.1054/bjoc.1999.0995] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
81 Yili Z, Xiaoyan H, Hongwen D, Yun Z, Xin C, Peng W, Youmin G. The value of diffusion-weighted imaging in assessing the ADC changes of tissues adjacent to breast carcinoma. BMC Cancer. 2009;9:18. [PMID: 19144163 DOI: 10.1186/1471-2407-9-18] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
82 Danaee H, Nelson HH, Karagas MR, Schned AR, Ashok TD, Hirao T, Perry AE, Kelsey KT. Microsatellite instability at tetranucleotide repeats in skin and bladder cancer. Oncogene 2002;21:4894-9. [PMID: 12118368 DOI: 10.1038/sj.onc.1205619] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]
83 Liu W, He L, Ramírez J, Ratain MJ. Interactions between MDM2 and TP53 Genetic Alterations, and Their Impact on Response to MDM2 Inhibitors and Other Chemotherapeutic Drugs in Cancer Cells. Clin Cancer Res 2009;15:7602-7. [PMID: 19996219 DOI: 10.1158/1078-0432.CCR-09-0890] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
84 Miller CW, Ikezoe T, Krug U, Hofmann WK, Tavor S, Vegesna V, Tsukasaki K, Takeuchi S, Koeffler HP. Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors. Genes Chromosomes Cancer 2002;33:17-21. [PMID: 11746983 DOI: 10.1002/gcc.1207] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 3.7] [Reference Citation Analysis]
85 Salgia R, Skarin AT. p53 and Bcl-2 in Small-Cell Lung Cancer. Clinical Lung Cancer 2003;4:303. [DOI: 10.1016/s1525-7304(11)70298-4] [Reference Citation Analysis]
86 Oh SJ, Ju J, Kim BC, Ko E, Hong BJ, Park JG, Park JW, Choi KY. DNA microarrays on a dendron-modified surface improve significantly the detection of single nucleotide variations in the p53 gene. Nucleic Acids Res 2005;33:e90. [PMID: 15939931 DOI: 10.1093/nar/gni087] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
87 Klein TJ, Glazer PM. The tumor microenvironment and DNA repair. Semin Radiat Oncol. 2010;20:282-287. [PMID: 20832021 DOI: 10.1016/j.semradonc.2010.05.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
88 Benavides MA, Oelschlager DK, Zhang H, Stockard CR, Vital-reyes VS, Katkoori VR, Manne U, Wang W, Bland KI, Grizzle WE. Methionine inhibits cellular growth dependent on the p53 status of cells. The American Journal of Surgery 2007;193:274-83. [DOI: 10.1016/j.amjsurg.2006.07.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
89 Sioris T, Husgafvel-pursiainen K, Karjalainen A, Anttila S, Kannio A, Salo JA, Perhoniemi V, Heikkil� L, Vainio H. Survival in operable non-small-cell lung cancer: Role of p53 mutations, tobacco smoking and asbestos exposure. Int J Cancer 2000;86:590-4. [DOI: 10.1002/(sici)1097-0215(20000515)86:4<590::aid-ijc23>3.0.co;2-e] [Cited by in Crossref: 26] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
90 Hainaut P, Hollstein M. p53 and human cancer: the first ten thousand mutations. Adv Cancer Res. 2000;77:81-137. [PMID: 10549356 DOI: 10.1016/s0065-230x(08)60785-x] [Cited by in Crossref: 572] [Cited by in F6Publishing: 260] [Article Influence: 24.9] [Reference Citation Analysis]
91 Hruban RH, Petersen GM, Ha PK, Kern SE. Genetics of Pancreatic Cancer. Surgical Oncology Clinics of North America 1998;7:1-23. [DOI: 10.1016/s1055-3207(18)30282-5] [Cited by in Crossref: 129] [Article Influence: 5.4] [Reference Citation Analysis]
92 Kochethu G, Delgado J, Pepper C, Starczynski J, Hooper L, Krishnan S, Fegan C, Pratt G. Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia. Leuk Res. 2006;30:1113-1118. [PMID: 16458962 DOI: 10.1016/j.leukres.2005.12.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]